| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |